Rossaphorn Kittiyaowamarn

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Global Antibiotic Research & Development Partnership(Current)

Ministry of Public Health

Örebro University

University College London

World Health Organization

Rossaphorn Kittiyaowamarn is an author at Global Antibiotic Research & Development Partnership specializing in microbiology, medical microbiology, and bacterial infections.

ORCID

Publications per year

2019–2025

Publications

Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial

Alison Luckey, Manica Balasegaram, Lindley A. Barbee et al. · The Lancet · 2025 · 29 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

High <i>In Vitro</i> Susceptibility to the First-in-Class Spiropyrimidinetrione Zoliflodacin among Consecutive Clinical Neisseria gonorrhoeae Isolates from Thailand and South Africa

Susanne Jacobsson, Ranmini Kularatne, Rossaphorn Kittiyaowamarn et al. · Antimicrobial Agents and Chemotherapy · 2019 · 21 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Genomic surveillance and antimicrobial resistance in <i>Neisseria gonorrhoeae</i> isolates in Bangkok, Thailand in 2018

Daniel Golparian, Rossaphorn Kittiyaowamarn, Porntip Paopang et al. · Journal of Antimicrobial Chemotherapy · 2022 · 17 citations

Life Sciences, Infectious Diseases, Microbiology +17

1–3 of 3